česky | english | sitemap

Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
NCI Bethesda System
HPV College


News for health professionals

Epidemiology of cervical cancer Screening process References


Year: 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

The Lancet publishes largest ever study on global burden of disease
13.12.2012 ecancer.org | More information...

The Lancet publishes the Global Burden of Disease Study 2010 (GBD 2010), the largest ever systematic effort to describe the global distribution and causes of a wide array of major diseases, injuries, and health risk factors.

Single HPV test 'predicts cancer risk for up to 18 years'
30.7.2012 Cancer Research UK | More information...

Testing women's smear test samples for the human papillomavirus (HPV) can predict who will develop early signs of cervical cancer up to 18 years later, US researchers have found.

Researchers identify cervical cells most susceptible to HPV infection
11.6.2012 Cancer Research UK | More information...

Only certain types of cells in a woman's cervix are vulnerable to infection by human papillomavirus (HPV) and lead to cancer, new research suggests.

New screening guidelines for cervical cancer
14.3.2012 American Cancer Society (ACS) | More information...

The American Cancer Society today released new screening recommendations for the prevention and early detection of cervical cancer. Screenings are tests for women who have no symptoms of cervical cancer. Among the changes: the American Cancer Society no longer recommends that women get a Pap test every year. Conclusions from the US, however, cannot be simply applied on the Czech population, as cervical cancer incidence among Czech women is almost three times as high as that in the US.